EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 28 / No 6-7 (Juin–Juillet 2012) Med Sci (Paris), 28 6-7 (2012) 625-632 References
Free Access
Issue
Med Sci (Paris)
Volume 28, Number 6-7, Juin–Juillet 2012
Page(s) 625 - 632
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2012286016
Published online 16 July 2012
  1. Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet 2005 ; 366 : 665–675. [CrossRef] [PubMed] [Google Scholar]
  2. Wallace MR, Marchuk DA, Andersen LB, et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 1990 ; 249 : 181–186. [CrossRef] [PubMed] [Google Scholar]
  3. Mulligan LM, Kwok JB, Healey CS, et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993 ; 363 : 458–460. [CrossRef] [PubMed] [Google Scholar]
  4. Gnarra JR, Tory K, Weng Y, et al. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 1994 ; 7 : 85–90. [CrossRef] [PubMed] [Google Scholar]
  5. Baysal BE, Ferrell RE, Willett-Brozick JE, et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000 ; 287 : 848–851. [CrossRef] [PubMed] [Google Scholar]
  6. Niemann S, Muller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 2000 ; 26 : 268–270. [CrossRef] [PubMed] [Google Scholar]
  7. Astuti D, Latif F, Dallol A, et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 2001 ; 69 : 49–54. [CrossRef] [PubMed] [Google Scholar]
  8. Dahia PL, Ross KN, Wright ME, et al. A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genet 2005 ; 1 : 72–80. [CrossRef] [PubMed] [Google Scholar]
  9. Eisenhofer G, Huynh TT, Pacak K, et al. Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome. Endocr Relat Cancer 2004 ; 11 : 897–911. [CrossRef] [PubMed] [Google Scholar]
  10. Lopez-Jimenez E, Gomez-Lopez G, Leandro-Garcia LJ, et al. Research resource: transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas. Mol Endocrinol 2010 ; 24 : 2382–2391. [CrossRef] [PubMed] [Google Scholar]
  11. Burnichon N, Vescovo L, Amar L, et al. Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma. Hum Mol Genet 2011 ; 20 : 3974–3985. [CrossRef] [PubMed] [Google Scholar]
  12. Favier J, Briere JJ, Burnichon N, et al. The warburg effect is genetically determined in inherited pheochromocytomas. PloS One 2009 ; 4 : e7094. [CrossRef] [PubMed] [Google Scholar]
  13. Qin Y, Yao L, King EE, et al. Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nat Genet 2010 ; 42 : 229–233. [CrossRef] [PubMed] [Google Scholar]
  14. Burnichon N, Briere JJ, Libe R, et al. SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet 2010 ; 19 : 3011–3020. [CrossRef] [PubMed] [Google Scholar]
  15. Comino-Mendez I, Gracia-Aznarez FJ, Schiavi F, et al. Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat Genet 2011 ; 43 : 663–667. [CrossRef] [PubMed] [Google Scholar]
  16. Van Nederveen FH, Gaal J, Favier J, et al. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol 2009 ; 10 : 764–771. [CrossRef] [PubMed] [Google Scholar]
  17. Pouyssegur J, Gothie E. HIF-1 : régulateur central de l’hypoxie. Med Sci (Paris) 2002 ; 18 : 70–78. [CrossRef] [EDP Sciences] [Google Scholar]
  18. Favier J, Gimenez-Roqueplo AP. Pheochromocytomas: the (pseudo)-hypoxic hypothesis. Best Pract Res Clin Endocrinol Metab 2010 ; 24 : 957–968. [CrossRef] [PubMed] [Google Scholar]
  19. Favier J, Igaz P, Burnichon N, et al. Rationale for anti-angiogenic therapy in pheochromocytoma and paraganglioma. Endocr Pathol 2011 ; 23 : 34–42. [CrossRef] [Google Scholar]
  20. Barontini M, Dahia PL. VHL disease. Best Pract Res Clin Endocrinol Metab 2010 ; 24 : 401–413. [CrossRef] [PubMed] [Google Scholar]
  21. Neumann HP, Bausch B, McWhinney SR, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002 ; 346 : 1459–1466. [CrossRef] [PubMed] [Google Scholar]
  22. Kloos RT, Eng C, Evans DB, et al. Medullary thyroid cancer: management guidelines of the American thyroid association. Thyroid 2009 ; 19 : 565–612. [CrossRef] [PubMed] [Google Scholar]
  23. Wolkenstein P. La neurofibromatose 1. Med Sci (Paris) 2001 ; 17 : 1158–1167. [CrossRef] [EDP Sciences] [Google Scholar]
  24. Bausch B, Koschker AC, Fassnacht M, et al. Comprehensive mutation scanning of NF1 in apparently sporadic cases of pheochromocytoma. J Clin Endocrinol Metab 2006 ; 91 : 3478–3481. [CrossRef] [PubMed] [Google Scholar]
  25. Korpershoek E, Favier J, Gaal J, et al. SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas. J Clin Endocrinol Metab 2011 ; 96 : E1472–E1476. [CrossRef] [PubMed] [Google Scholar]
  26. Hao HX, Khalimonchuk O, Schraders M, et al. SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 2009 ; 325 : 1139–1142. [CrossRef] [PubMed] [Google Scholar]
  27. Bayley JP, Kunst HP, Cascon A, et al. SDHAF2 mutations in familial and sporadic paraganglioma and pheochromocytoma. Lancet Oncol 2010 ; 11 : 366–372. [CrossRef] [PubMed] [Google Scholar]
  28. Kunst HP, Rutten MH, de Monnink JP, et al. SDHAF2 (PGL2-SDH5) and hereditary head and neck paraganglioma. Clin Cancer Res 2011 ; 17 : 247–254. [CrossRef] [PubMed] [Google Scholar]
  29. Burnichon N, Lepoutre-Lussey C, Laffaire J, et al. A novel TMEM127 mutation in a patient with familial bilateral pheochromocytoma. Eur J Endocrinol 2011 ; 164 : 141–145. [CrossRef] [PubMed] [Google Scholar]
  30. Yao L, Schiavi F, Cascon A, et al. Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas. JAMA 2010 ; 304 : 2611–2619. [CrossRef] [PubMed] [Google Scholar]
  31. Grandori C, Cowley SM, James LP, Eisenman RN. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 2000 ; 16 : 653–699. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.